Reduced expression of autotaxin predicts survival in uveal melanoma

Aim: In an effort to identify patients with uveal melanoma at high risk of metastasis, the authors undertook correlation of gene expression profiles with histopathology data and tumour-related mortality. Methods: The RNA was isolated from 27 samples of uveal melanoma from patients who had consented to undergo enucleation, and transcripts profiled using a cDNA array comprised of sequence-verified cDNA clones representing approximately 4000 genes implicated in cancer development. Two multivariate data mining techniques—hierarchical cluster analysis and multidimensional scaling—were used to investigate the grouping structure in the gene expression data. Cluster analysis was performed with a subset of 10 000 randomly selected genes and the cumulative contribution of all the genes in making the correct grouping was recorded. Results: Hierarchical cluster analysis and multidimensional scaling revealed two distinct classes. When correlated with the data on metastasis, the two molecular classes corresponded very well to the survival data for the 27 patients. Thirty two discrete genes (corresponding to 44 probe sets) that correctly defined the molecular classes were selected. A single gene (ectonucleotide pyrophosphatase/phosphodiesterase 2; autotaxin) could classify the molecular types. The expression pattern was confirmed using real-time quantitative PCR. Conclusions: Gene expression profiling identifies two distinct prognostic classes of uveal melanoma. Underexpression of autotaxin in class 2 uveal melanoma with a poor prognosis needs to be explored further.

[1]  E. Antecka,et al.  Identification of circulating malignant cells and its correlation with prognostic factors and treatment in uveal melanoma. A prospective longitudinal study , 2007, Eye.

[2]  Arie Perry,et al.  Transcriptomic versus Chromosomal Prognostic Markers and Clinical Outcome in Uveal Melanoma , 2007, Clinical Cancer Research.

[3]  Y. Kishi,et al.  Autotaxin Is Overexpressed in Glioblastoma Multiforme and Contributes to Cell Motility of Glioblastoma by Converting Lysophosphatidylcholine TO Lysophosphatidic Acid* , 2006, Journal of Biological Chemistry.

[4]  Justis P. Ehlers,et al.  Functional gene expression analysis uncovers phenotypic switch in aggressive uveal melanomas. , 2006, Cancer research.

[5]  D. Edwards,et al.  Metalloproteinases and their inhibitors in tumor angiogenesis , 2005, International journal of cancer.

[6]  M. Bollen,et al.  Proteolytic maturation and activation of autotaxin (NPP2), a secreted metastasis-enhancing lysophospholipase D , 2005, Journal of Cell Science.

[7]  M. Herlyn,et al.  Adhesion, migration and communication in melanocytes and melanoma. , 2005, Pigment cell research.

[8]  A. Reeve,et al.  A gene expression signature for relapse of primary wilms tumors. , 2005, Cancer research.

[9]  Arun D. Singh,et al.  Uveal melanoma: epidemiologic aspects. , 2005, Ophthalmology clinics of North America.

[10]  B. Williams,et al.  Transcript profiling of Wilms tumors reveals connections to kidney morphogenesis and expression patterns associated with anaplasia , 2005, Oncogene.

[11]  Justis P. Ehlers,et al.  Gene Expression Profiling in Uveal Melanoma Reveals Two Molecular Classes and Predicts Metastatic Death , 2004, Cancer Research.

[12]  G. Mills,et al.  Lysophosphatidic acid production and action: Validated targets in cancer? , 2004, Journal of cellular biochemistry.

[13]  B. Giepmans,et al.  The ins and outs of lysophosphatidic acid signaling , 2004, BioEssays : news and reviews in molecular, cellular and developmental biology.

[14]  H. Dralle,et al.  Expression, regulation and function of autotaxin in thyroid carcinomas , 2004, International journal of cancer.

[15]  R. Frants,et al.  Gene expression profiling identifies tumour markers potentially playing a role in uveal melanoma development , 2003, British Journal of Cancer.

[16]  T. Kivelä,et al.  Very long-term prognosis of patients with malignant uveal melanoma. , 2003, Investigative ophthalmology & visual science.

[17]  C. Shields Incidence of Uveal Melanoma in the United States: 1973–1997 , 2003 .

[18]  S. Pavey,et al.  Expression profiling reveals that methylation of TIMP3 is involved in uveal melanoma development , 2003, International journal of cancer.

[19]  Eric R. Ziegel,et al.  The Elements of Statistical Learning , 2003, Technometrics.

[20]  K. Jöckel,et al.  Tumor classification based on gene expression profiling shows that uveal melanomas with and without monosomy 3 represent two distinct entities. , 2003, Cancer research.

[21]  Arun D. Singh,et al.  Incidence of uveal melanoma in the United States: 1973-1997. , 2003, Ophthalmology.

[22]  Arun D. Singh,et al.  Survival rates with uveal melanoma in the United States: 1973-1997. , 2003, Ophthalmology.

[23]  Tala Bakheet,et al.  p38 Mitogen-Activated Protein Kinase-Dependent and -Independent Signaling of mRNA Stability of AU-Rich Element-Containing Transcripts , 2003, Molecular and Cellular Biology.

[24]  Hyun Cheol Chung,et al.  Expression of autotaxin (NPP-2) is closely linked to invasiveness of breast cancer cells , 2002, Clinical & Experimental Metastasis.

[25]  G. Mills,et al.  Autotaxin has lysophospholipase D activity leading to tumor cell growth and motility by lysophosphatidic acid production , 2002, The Journal of cell biology.

[26]  R. Kiessling,et al.  HLA expression in uveal melanoma: there is no rule without some exception. , 2002, Human immunology.

[27]  J. Earle,et al.  THE COMS RANDOMIZED TRIAL OF IODINE 125 BRACHYTHERAPY FOR CHOROIDAL MELANOMA, III: INITIAL MORTALITY FINDINGS COMS REPORT NO. 18 , 2002 .

[28]  Y. S. Kim,et al.  Autotaxin (NPP-2), a metastasis-enhancing motogen, is an angiogenic factor. , 2001, Cancer research.

[29]  A. Tarkkanen,et al.  Tumor-infiltrating macrophages (CD68(+) cells) and prognosis in malignant uveal melanoma. , 2001, Investigative ophthalmology & visual science.

[30]  C. Shields,et al.  Prognostic factors in uveal melanoma , 2001, Melanoma research.

[31]  G. Mann,et al.  Responses to ultraviolet-B in cell lines from hereditary melanoma kindreds , 2001, Melanoma research.

[32]  F. Marincola,et al.  High-fidelity mRNA amplification for gene profiling , 2000, Nature Biotechnology.

[33]  M. Tsao,et al.  Autotaxin expression in non-small-cell lung cancer. , 1999, American journal of respiratory cell and molecular biology.

[34]  D. Botstein,et al.  Cluster analysis and display of genome-wide expression patterns. , 1998, Proceedings of the National Academy of Sciences of the United States of America.

[35]  Jennifer I. Lim,et al.  The Collaborative Ocular Melanoma Study (COMS) randomized trial of pre-enucleation radiation of large choroidal melanoma II: initial mortality findings. COMS report no. 10. , 1998, American journal of ophthalmology.

[36]  V. Kähäri,et al.  Adenovirus-mediated gene delivery of tissue inhibitor of metalloproteinases-3 inhibits invasion and induces apoptosis in melanoma cells. , 1998, Cancer research.

[37]  M. Hendrix,et al.  Biologic determinants of uveal melanoma metastatic phenotype: role of intermediate filaments as predictive markers. , 1998, Laboratory investigation; a journal of technical methods and pathology.

[38]  R. Rees,et al.  Abnormalities of chromosomes 3 and 8 in posterior uveal melanoma correlate with prognosis , 1997, Genes, chromosomes & cancer.

[39]  I. McLean,et al.  Uveal melanoma , 1997, Cancer.

[40]  N. Bornfeld,et al.  Prognostic implications of monosomy 3 in uveal melanoma , 1996, The Lancet.

[41]  C. Shields,et al.  Cytogenetic findings in primary uveal melanoma. , 1994, Cancer genetics and cytogenetics.

[42]  R. Folberg,et al.  The prognostic value of tumor blood vessel morphology in primary uveal melanoma. , 1993, Ophthalmology.

[43]  R. Folberg,et al.  The morphologic characteristics of tumor blood vessels as a marker of tumor progression in primary human uveal melanoma: a matched case-control study. , 1992, Human pathology.

[44]  H. Krutzsch,et al.  Identification, purification, and partial sequence analysis of autotaxin, a novel motility-stimulating protein. , 1992, The Journal of biological chemistry.

[45]  B. Hawkins,et al.  A review of mortality from choroidal melanoma. II. A meta-analysis of 5-year mortality rates following enucleation, 1966 through 1988. , 1992, Archives of ophthalmology.

[46]  N. Bornfeld,et al.  Nonrandom chromosomal abnormalities in primary uveal melanoma. , 1990, Journal of the National Cancer Institute.

[47]  Arun D. Singh,et al.  CHAPTER 35 – Uveal malignant melanoma: epidemiologic aspects , 2007 .

[48]  S. Fine Collaborative ocular melanoma study group. , 1999, Archives of family medicine.

[49]  B. Melia,et al.  Mortality in patients with small choroidal melanoma the collaborative ocular melanoma study-group members of the writing team, who signed authorship responsibility, financial disclosure, and copyright transfer statements for the group are as follows , 1997 .

[50]  Mortality in patients with small choroidal melanoma. COMS report no. 4. The Collaborative Ocular Melanoma Study Group. , 1997, Archives of ophthalmology.

[51]  C. Shields,et al.  Clinical genetics of retinoblastoma. , 1993, International ophthalmology clinics.

[52]  Accuracy of diagnosis of choroidal melanomas in the Collaborative Ocular Melanoma Study. COMS report no. 1. , 1990, Archives of ophthalmology.

[53]  R. Glynn,et al.  Epidemiologic aspects of uveal melanoma. , 1988, Survey of ophthalmology.